These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 16849578

  • 1. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.
    den Brok MH, Sutmuller RP, Nierkens S, Bennink EJ, Toonen LW, Figdor CG, Ruers TJ, Adema GJ.
    Cancer Res; 2006 Jul 15; 66(14):7285-92. PubMed ID: 16849578
    [Abstract] [Full Text] [Related]

  • 2. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.
    den Brok MH, Sutmuller RP, Nierkens S, Bennink EJ, Frielink C, Toonen LW, Boerman OC, Figdor CG, Ruers TJ, Adema GJ.
    Br J Cancer; 2006 Oct 09; 95(7):896-905. PubMed ID: 16953240
    [Abstract] [Full Text] [Related]

  • 3. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR.
    J Immunother; 2007 Oct 09; 30(8):789-97. PubMed ID: 18049330
    [Abstract] [Full Text] [Related]

  • 4. Saponin-based adjuvants create a highly effective anti-tumor vaccine when combined with in situ tumor destruction.
    den Brok MH, Nierkens S, Wagenaars JA, Ruers TJ, Schrier CC, Rijke EO, Adema GJ.
    Vaccine; 2012 Jan 17; 30(4):737-44. PubMed ID: 22138178
    [Abstract] [Full Text] [Related]

  • 5. Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model.
    Pilon-Thomas S, Li W, Briggs JJ, Djeu J, Mulé JJ, Riker AI.
    J Immunother; 2006 Jan 17; 29(4):381-7. PubMed ID: 16799333
    [Abstract] [Full Text] [Related]

  • 6. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL, Parish CR, Demangel C, Britton WJ, Altin JG.
    Cancer Res; 2004 Jun 15; 64(12):4357-65. PubMed ID: 15205352
    [Abstract] [Full Text] [Related]

  • 7. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses.
    Du YC, Lin P, Zhang J, Lu YR, Ning QZ, Wang Q.
    Tissue Antigens; 2006 May 15; 67(5):368-76. PubMed ID: 16671943
    [Abstract] [Full Text] [Related]

  • 8. Potent in vivo anti-tumor activity of isolated CD62L(low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines.
    Liu Z, Fan H, Wu Y, Chen B.
    Cytotherapy; 2005 May 15; 7(4):353-62. PubMed ID: 16162457
    [Abstract] [Full Text] [Related]

  • 9. Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy.
    Boczkowski D, Lee J, Pruitt S, Nair S.
    Cancer Gene Ther; 2009 Dec 15; 16(12):900-11. PubMed ID: 19498460
    [Abstract] [Full Text] [Related]

  • 10. Class C CpG oligodeoxynucleotides as a single agent and in combination with radiotherapy efficiently delayed growth of subcutaneous B16F1 tumors.
    Cerkovnik P, Jezersek Novakovic B, Stegel V, Novakovic S.
    Innate Immun; 2009 Oct 15; 15(5):313-21. PubMed ID: 19723833
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M, Kudo-Saito C, Hasegawa G, Yano K, Yamamoto A, Yaguchi M, Toda M, Azuma I, Iwai T, Kawakami Y.
    Clin Cancer Res; 2006 Dec 15; 12(24):7465-75. PubMed ID: 17189420
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction.
    Okada N, Mori N, Koretomo R, Okada Y, Nakayama T, Yoshie O, Mizuguchi H, Hayakawa T, Nakagawa S, Mayumi T, Fujita T, Yamamoto A.
    Gene Ther; 2005 Jan 15; 12(2):129-39. PubMed ID: 15483669
    [Abstract] [Full Text] [Related]

  • 16. In vivo colocalization of antigen and CpG [corrected] within dendritic cells is associated with the efficacy of cancer immunotherapy.
    Nierkens S, den Brok MH, Sutmuller RP, Grauer OM, Bennink E, Morgan ME, Figdor CG, Ruers TJ, Adema GJ.
    Cancer Res; 2008 Jul 01; 68(13):5390-6. PubMed ID: 18593941
    [Abstract] [Full Text] [Related]

  • 17. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
    Motomura Y, Senju S, Nakatsura T, Matsuyoshi H, Hirata S, Monji M, Komori H, Fukuma D, Baba H, Nishimura Y.
    Cancer Res; 2006 Feb 15; 66(4):2414-22. PubMed ID: 16489048
    [Abstract] [Full Text] [Related]

  • 18. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 15; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 19. Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy.
    Heckelsmiller K, Beck S, Rall K, Sipos B, Schlamp A, Tuma E, Rothenfusser S, Endres S, Hartmann G.
    Eur J Immunol; 2002 Nov 15; 32(11):3235-45. PubMed ID: 12555669
    [Abstract] [Full Text] [Related]

  • 20. [A possibility of overcoming local tumor immune tolerance by radiofrequency ablation in combination with intratumoral injection of naïve dendritic cell].
    Saji H, Song W, Nakamura H, Saijo T, Hosaka M, Hagiwara M, Ogata A, Kawasaki N, Engleman EG, Kato H.
    Gan To Kagaku Ryoho; 2006 Nov 15; 33(12):1736-8. PubMed ID: 17212091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.